A specialty pharmaceutical company focused on acquiring, licensing, and commercializing late‑stage medicines primarily in cardiovascular and central nervous system disorders. Its portfolio includes products such as Vascepa for cardiovascular risk reduction and Clozaril for treatment‑resistant schizo...
1 member of Congress has disclosed 1 trade in HLS Inc (HLS), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2014-03-07 | JOHN K. DELANEY | sell | $1K – $15K |